Autor: |
Floris S; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy., Fais A; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy., Medda R; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy., Pintus F; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy., Piras A; Department of Chemical and Geological Sciences, University of Cagliari, Cagliari, Italy., Kumar A; Department of Electrical and Electronic Engineering, University of Cagliari, Cagliari, Italy., Kuś PM; Department of Pharmacognosy and Herbal Medicines, Wroclaw Medical University, Wrocław, Poland., Westermark GT; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden., Era B; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy. |
Abstrakt: |
Washingtonia filifera seeds have revealed to possess antioxidant properties, butyrylcholinesterase and xanthine oxidase inhibition activities. The literature has indicated a relationship between Alzheimer's disease (AD) and type-2 diabetes (T2D). Keeping this in mind, we have now evaluated the inhibitory properties of W. filifera seed extracts on α -amylase, α -glucosidase enzyme activity and the Islet Amyloid Polypeptide (IAPP) fibrils formation. Three extracts from seeds of W. filifera were evaluated for their enzyme inhibitory effect and IC 50 values were calculated for all the extracts. The inhibition mode was investigated by Lineweaver-Burk plot analysis and the inhibition of IAPP aggregate formation was monitored. W. filifera methanol seed extract appears as the most potent inhibitor of α-amylase, α-glucosidase, and for the IAPP fibril formation. Current findings indicate new potential of this extract that could be used for the identification or development of novel potential agents for T2D and AD. |